{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:30:26Z","timestamp":1778761826499,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.psyneuen.2018.04.029","type":"journal-article","created":{"date-parts":[[2018,5,6]],"date-time":"2018-05-06T09:46:22Z","timestamp":1525599982000},"page":"25-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Changes in the tryptophan-kynurenine axis in association to therapeutic response in clinically depressed patients undergoing psychiatric rehabilitation"],"prefix":"10.1016","volume":"94","author":[{"given":"B.","family":"Reininghaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Riedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Dalkner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.A.","family":"Bengesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Birner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Platzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Hamm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Gostner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-9563","authenticated-orcid":false,"given":"D.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.Z.","family":"Reininghaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2018.04.029_bib0005","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-014-0541-1","article-title":"Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites","volume":"17","author":"Anderson","year":"2015","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0010","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neubiorev.2010.10.001","article-title":"Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors","volume":"35","author":"Berk","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0015","doi-asserted-by":"crossref","first-page":"e0135313","DOI":"10.1371\/journal.pone.0135313","article-title":"Cerebral white matter lesions and affective episodes correlate in male individuals with bipolar disorder","volume":"10","author":"Birner","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0165-0327(02)00264-1","article-title":"Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus","volume":"72","author":"Bonaccorso","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00004714-200202000-00014","article-title":"Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system","volume":"22","author":"Bonaccorso","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0030","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1381\/096089206776945066","article-title":"Bariatric surgery cannot prevent tryptophan depletion due to chronic immune activation in morbidly obese patients","volume":"16","author":"Brandacher","year":"2006","journal-title":"Obes. Surg."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0035","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/138920007780362590","article-title":"Chronic immune activation underlies morbid obesity: is IDO a key player?","volume":"8","author":"Brandacher","year":"2007","journal-title":"Curr. Drug Metab."},{"issue":"Suppl. (1)","key":"10.1016\/j.psyneuen.2018.04.029_bib0040","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/S0889-1591(02)00078-8","article-title":"Cytokines and depression: the need for a new paradigm","volume":"17","author":"Capuron","year":"2003","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0045","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/sj.mp.4000995","article-title":"Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy","volume":"7","author":"Capuron","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0050","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0006-3223(03)00173-2","article-title":"Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment","volume":"54","author":"Capuron","year":"2003","journal-title":"Biol. Psychiatry."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0055","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.psyneuen.2015.02.011","article-title":"2015 Ongoing episode of major depressive disorder is not associated with elevated plasma levels of kynurenine pathway markers","volume":"56","author":"Dahl","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0060","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0065","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1002\/oby.21199","article-title":"The kynurenine pathway is activated in human obesity and shifted toward kynurenine monooxygenase activation","volume":"23","author":"Favennec","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0070","first-page":"873","article-title":"Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic\/psychiatric symptoms","volume":"3","author":"Fuchs","year":"1990","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbi.2015.02.029","article-title":"The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway","volume":"48","author":"Guloksuz","year":"2015","journal-title":"Brain Behav. Immun."},{"issue":"-67","key":"10.1016\/j.psyneuen.2018.04.029_bib0080","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpsychires.2015.04.026","article-title":"Does escitalopram reduce neurotoxicity in major depression?","volume":"66","author":"Halaris","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"12","key":"10.1016\/j.psyneuen.2018.04.029_bib0085","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1038\/npp.2011.132","article-title":"The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis","volume":"36","author":"Hannestad","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0090","series-title":"Beck depressions-inventar (BDI-II). frankfurt: harcourt test services","author":"Hautzinger","year":"2006"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0095","first-page":"S1","article-title":"The importance of medical-psychiatric rehabilitation","volume":"21","author":"Hinterhuber","year":"2007","journal-title":"Neuropsychiatr"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00702-011-0668-8","article-title":"New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid\/3-hydroxykynurenine ratio","volume":"119","author":"Kocki","year":"2012","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0105","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PSY.0000000000000339","article-title":"Depression phenotype, inflammation, and the brain: implications for future research","volume":"78","author":"Krishnadas","year":"2016","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0110","first-page":"3","article-title":"The increasing burden of depression","volume":"7","author":"Lepine","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0115","article-title":"Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome","author":"Mangge","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","article-title":"Serotonin, tryptophan metabolism and the brain-gut-microbiome axis","volume":"277","author":"O'Mahony","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"July","key":"10.1016\/j.psyneuen.2018.04.029_bib0130","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.psyneuen.2017.04.015","article-title":"Tryptophan breakdown and cognition in bipolar disorder","volume":"81","author":"Platzer","year":"2017","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psyneuen.2018.01.024","article-title":"The relationship between inflammatory state and quantity of affective episodes in bipolar disorder","volume":"90","author":"Queissner","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0140","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/archgenpsychiatry.2010.161","article-title":"Inflammation, sanitation, and consternation: loss of contact with coevolved: tolerogenic microorganisms and the pathophysiology and treatment of major depression","volume":"67","author":"Raison","year":"2010","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/mp.2008.58","article-title":"Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol. Psychiatry."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0155","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bdi.12166","article-title":"Tryptophan breakdown is increased in euthymic overweight individuals with bipolar disorder: a preliminary report","volume":"16","author":"Reininghaus","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0160","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0889-1591(02)00006-5","article-title":"Neopterin production, tryptophan degradation, and mental depression\u2013what is the link?","volume":"16","author":"Widner","year":"2002","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0165","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1152\/ajpregu.00373.2011","article-title":"Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone","volume":"303","author":"Wolowczuk","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.psyneuen.2018.04.029_bib0170","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2174\/1570159X14666151208113006","article-title":"Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression","volume":"14","author":"Won","year":"2016","journal-title":"Curr. Neuropharmacol."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453018302828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453018302828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:00:52Z","timestamp":1759683652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453018302828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":34,"alternative-id":["S0306453018302828"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.04.029","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in the tryptophan-kynurenine axis in association to therapeutic response in clinically depressed patients undergoing psychiatric rehabilitation","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}